跳至主要内容
临床试验/NCT02201017
NCT02201017Unknown不适用

HeartTrends HRV Algorithm for the Detection of Myocardial Ischemia

Sheba Medical Center2 个研究点 分布在 2 个国家目标入组 621 人开始时间: 2014年6月最近更新:
适应症

试验速览

阶段
不适用
入组人数
621
试验地点
2
主要终点
Positive percent agreement

研究概览

简要总结

A total of 621 consecutive male and female subjects, without established CAD, referred to exercise stress testing (EST) due to 1) chest pain syndromes or equivocal/equivalent angina with intermediate pretest probability for CAD; 2) , or asymptomatic subjects with diabetes mellitus who are referred EST for risk assessment prior to initiation of an exercise program.

To validate the diagnostic performance of the HeartTrends device for the detection and ruling out of myocardial ischemia in a population of subjects who are currently referred for cardiovascular evaluation using EST.

Prospective multicenter single-armed study, assessing the diagnostic accuracy of HRV analysis by the HeartTrends device for the detection of myocardial ischemia, as determined by stress echocardiography.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • No known CAD
  • Referral for EST due to either one of the following two indications:
  • Chest pain syndrome or equivocal angina in subjects with intermediate pretest probability of CAD according to the 2002 updated guidelines for exercise stress examination.1 (See definition of intermediate pretest probability of CAD in Supplementary Appendix Table at the end of this document); or
  • Asymptomatic subjects with diabetes mellitus referred to EST for risk assessment prior to initiation of an exercise program.
  • Willing and able to provide written informed consent

排除标准

  • Acute Coronary Syndrome
  • Established CAD
  • Atrial fibrillation or flutter
  • Cardiac Pacemaker
  • Clinical diagnosis of heart failure
  • Severe COPD (FEV1< 50% predicted value)
  • Active myocarditis, constrictive pericarditis, any cardiomyopathy, cardiac or systemic amyloidosis
  • Known drug or alcohol dependence or any other factors which will interfere with the study conduct or interpretation of the results or in the opinion of the investigator are not suitable to participate;
  • Any illness that might reduce life expectancy to less than 1 year from screening
  • Left bundle branch block (LBBB), significant intra-ventricular conduction delay (IVCD) or significant (>1mm) ST deviations on baseline ECG
  • Inability to perform an exercise stress test (i.e. orthopedical or neurological limitations)
  • Any significant valvular disease defined as:
  • Established valvular regurgitation or stenosis abnormality above moderate severity
  • BMI >35 kg/m2
  • Recent (< 6 months) history of pulmonary embolism

结局指标

主要结局

Positive percent agreement

时间窗: 1 year

Positive percent agreement of ≥70% (with a lower confidence interval of 60%) between a positive HRV HeartTrends test and a positive ESE

次要结局

  • negative percent agreement(1 year)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

HeartTrends HRV Algorithm for the Detection of... | 临床试验